2196 related articles for article (PubMed ID: 7872665)
21. Modifications of the antioxidant enzymes in relation to chromosome imbalances in human melanoma cell lines.
Bravard A; Cherbonnel-Lasserre C; Reillaudou M; Beaumatin J; Dutrillaux B; Luccioni C
Melanoma Res; 1998 Aug; 8(4):329-35. PubMed ID: 9764808
[TBL] [Abstract][Full Text] [Related]
22. The National Cancer Data Base report on cancer of the vagina.
Creasman WT; Phillips JL; Menck HR
Cancer; 1998 Sep; 83(5):1033-40. PubMed ID: 9731908
[TBL] [Abstract][Full Text] [Related]
23. Melanocytic naevus or malignant melanoma? A large-scale epidemiological study of diagnostic accuracy.
Lindelöf B; Hedblad MA; Sigurgeirsson B
Acta Derm Venereol; 1998 Jul; 78(4):284-8. PubMed ID: 9689297
[TBL] [Abstract][Full Text] [Related]
24. Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma.
Heaton KM; Sussman JJ; Gershenwald JE; Lee JE; Reintgen DS; Mansfield PF; Ross MI
Ann Surg Oncol; 1998 Jun; 5(4):322-8. PubMed ID: 9641453
[TBL] [Abstract][Full Text] [Related]
25. Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity.
Marchetti D; Nicolson GL
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):99-105. PubMed ID: 9487024
[TBL] [Abstract][Full Text] [Related]
26. Avoidable cancers in the Nordic countries. Radiation.
Winther JF; Ulbak K; Dreyer L; Pukkala E; Osterlind A
APMIS Suppl; 1997; 76():83-99. PubMed ID: 9462822
[TBL] [Abstract][Full Text] [Related]
27. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
Kim CJ; Parkinson DR; Marincola F
J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
[TBL] [Abstract][Full Text] [Related]
28. Enhanced anti-tumor effect of an IFN-gamma-EGF fusion protein.
Chen WQ; Ding YP; Zhang LL; Hou YD
Biomed Environ Sci; 1997 Dec; 10(4):387-95. PubMed ID: 9448920
[TBL] [Abstract][Full Text] [Related]
29. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
Luca M; Huang S; Gershenwald JE; Singh RK; Reich R; Bar-Eli M
Am J Pathol; 1997 Oct; 151(4):1105-13. PubMed ID: 9327744
[TBL] [Abstract][Full Text] [Related]
30. Prediction of outcome for patients with cutaneous melanoma.
Cochran AJ
Pigment Cell Res; 1997 Jun; 10(3):162-7. PubMed ID: 9266604
[TBL] [Abstract][Full Text] [Related]
31. Melanoma cell adhesion to injured arterioles: mechanisms of stabilized tethering.
Kong L; Korthuis RJ
Clin Exp Metastasis; 1997 Jul; 15(4):426-31. PubMed ID: 9219731
[TBL] [Abstract][Full Text] [Related]
32. The aging skin.
Bergfeld WF
Int J Fertil Womens Med; 1997; 42(2):57-66. PubMed ID: 9160214
[TBL] [Abstract][Full Text] [Related]
33. Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived).
Diebold Y; Blanco G; Saornil MA; Fernández N; Lázaro MC
Curr Eye Res; 1997 May; 16(5):487-95. PubMed ID: 9154388
[TBL] [Abstract][Full Text] [Related]
34. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
[TBL] [Abstract][Full Text] [Related]
35. A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma.
McClay EF; McClay ME; Jones JA; Winski PJ; Christen RD; Howell SB; Hall PD
Cancer; 1997 Mar; 79(5):1037-43. PubMed ID: 9041168
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma.
Lissoni P; Brivio O; Brivio F; Barni S; Tancini G; Crippa D; Meregalli S
J Pineal Res; 1996 Nov; 21(4):239-42. PubMed ID: 8989723
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in 'poor-risk' metastatic melanoma.
Proebstle TM; Scheibenbogen C; Sterry W; Keilholz U
Eur J Cancer; 1996 Aug; 32A(9):1530-3. PubMed ID: 8911113
[TBL] [Abstract][Full Text] [Related]
39. Increase in shedding of intercellular adhesion molecule-1 in human malignant melanoma cell lines treated with hyperthermia in vitro.
Nakayama J; Kageshita T; Nakashima M; Tsujisaki M; Imai K; Hori Y
Pigment Cell Res; 1996 Jun; 9(3):154-8. PubMed ID: 8888315
[TBL] [Abstract][Full Text] [Related]
40. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models.
De Flora S; D'Agostini F; Masiello L; Giunciuglio D; Albini A
Int J Cancer; 1996 Sep; 67(6):842-8. PubMed ID: 8824557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
